Schenck M - Search Results

1

[Effect of disturbing factors on the specificity of exfoliative urinary cytology].

Busch Y, vom Dorp F, Schenck M, Rossi R, Witschier J, Rübben H. Busch Y, et al. Among authors: schenck m. Urologe A. 2007 Sep;46(9):1141-4. doi: 10.1007/s00120-007-1469-4. Urologe A. 2007. PMID: 17619843 German.

2

[Use of silicon chip technology to detect protein-based tumor markers in bladder cancer].

Jäger T, Szarvas T, vom Dorp F, Börgermann C, Schenck M, Schmid KW, Rübben H. Jäger T, et al. Among authors: schenck m. Urologe A. 2007 Sep;46(9):1152-6. doi: 10.1007/s00120-007-1429-z. Urologe A. 2007. PMID: 17593336 German.

3

[Role of lymphadenectomy in patients with invasive urothelial carcinoma of the bladder].

vom Dorp F, Börgermann C, Schenck M, Becker M, Rose A, Szarvas T, Rübben H. vom Dorp F, et al. Among authors: schenck m. Urologe A. 2009 Jan;48(1):51-3. doi: 10.1007/s00120-008-1760-z. Urologe A. 2009. PMID: 19048222 Review. German.

4

[Informed consent for patients on early recognition of prostate carcinoma is insufficient].

Börgermann C, vom Dorp F, Rossi R, Schenck M, Luboldt HJ, Rübben H. Börgermann C, et al. Among authors: schenck m. Urologe A. 2009 Sep;48(9):997-8, 1000-1. doi: 10.1007/s00120-009-2074-5. Urologe A. 2009. PMID: 19680621 German.

5

[Plasma E-cadherin levels in urinary bladder cancer: does it improve risk stratification?].

Szarvas T, Hoffmann F, Becker M, Schenck M, Vom Dorp F, Rübben H, Jäger T. Szarvas T, et al. Among authors: schenck m. Urologe A. 2011 Jan;50(1):64-70. doi: 10.1007/s00120-010-2454-x. Urologe A. 2011. PMID: 21153394 German.

6

Correlation of pathological and cytological-cytometric grading of transitional cell carcinoma of the urinary tract.

Vom Dorp F, Pal P, Tschirdewahn S, Rossi R, Börgermann C, Schenck M, Becker M, Szarvas T, Hakenberg OW, Rübben H. Vom Dorp F, et al. Among authors: schenck m. Urol Int. 2011;86(1):36-40. doi: 10.1159/000321017. Epub 2010 Dec 16. Urol Int. 2011. PMID: 21160157

7

[Inhaled immunotherapy for pulmonary metastases of renal cell cancer].

Lümmen G, Schenck M, Börgermann C, Eisenhardt A, Vom Dorp F, Sperling H, Rübben H. Lümmen G, et al. Among authors: schenck m. Urologe A. 2004 Apr;43(4):457-61. doi: 10.1007/s00120-004-0538-1. Urologe A. 2004. PMID: 15085267 Clinical Trial. German.

8

[Principle problems of lymph node surgery].

Schenck M, Lümmen G, Stuschke M, Schmid KW, Rübben H. Schenck M, et al. Urologe A. 2005 Jun;44(6):605-7. doi: 10.1007/s00120-005-0822-8. Urologe A. 2005. PMID: 15871007 German. No abstract available.

9

[Immunotherapy of metastatic renal cell carcinoma with interleukin-2, interferon-alpha2a and erythropoietin-beta].

Schenck M, Börgermann C, Jäger T, vom Dorp F, Sperling H, Rübben H, Lümmen G. Schenck M, et al. Urologe A. 2007 May;46(5):528-34. doi: 10.1007/s00120-007-1313-x. Urologe A. 2007. PMID: 17356836 Clinical Trial. German.

10

[Proapoptotic antibodies as new therapeutic agents for tumor treatment].

Schenck M, Börgermann C, vom Dorp F, Groneberg M, Busch Y, Carpinteiro A, Wilker B, Keitsch S, Moyrer S, Schmid KW, Stuschke M, Rübben H, Gulbins E. Schenck M, et al. Urologe A. 2007 Sep;46(9):1262-5. doi: 10.1007/s00120-007-1385-7. Urologe A. 2007. PMID: 17598083 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

108 results

Search Page

Filters